Expert Opinion on Drug Metabolism & Toxicology, Volume 14, Issue 3 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 14, Issue 3 (2018)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Volume 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Review

Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects
Asher Ornoy & Gideon Koren
Pages: 247-259
Published online: 24 Jan 2018
AbstractforSelective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects | Full Text | References | PDF (961.8 KB)
  • 733 Views
  • 4 CrossRef citations
  • 0Altmetric
Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions
A. Sullivan, J. Watkinson, J. Waddington, B. K. Park & D. J. Naisbitt
Pages: 261-274
Published online: 22 Feb 2018
AbstractforImplications of HLA-allele associations for the study of type IV drug hypersensitivity reactions | Full Text | References | PDF (1.5 MB)
  • 364 Views
  • 2 CrossRef citations
  • 0Altmetric
Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Cornelis Smit, Sjoerd De Hoogd, Roger J.M. Brüggemann & Catherijne A. J. Knibbe
Pages: 275-285
Published online: 15 Feb 2018
AbstractforObesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters | Full Text | References | PDF (1.9 MB)
  • 4420 Views
  • 99 CrossRef citations
  • 0Altmetric
Drug metabolism in early infancy: opioids as an illustration
Tamara Van Donge, Paola Mian, Dick Tibboel, John Van Den Anker & Karel Allegaert
Pages: 287-301
Published online: 30 Jan 2018
AbstractforDrug metabolism in early infancy: opioids as an illustration | Full Text | References | PDF (1.2 MB)
  • 660 Views
  • 15 CrossRef citations
  • 0Altmetric
P2Y12 receptor inhibitors: an evolution in drug design to prevent arterial thrombosis
Danny Kupka & Dirk Sibbing
Pages: 303-315
Published online: 23 Jan 2018
AbstractforP2Y12 receptor inhibitors: an evolution in drug design to prevent arterial thrombosis | Full Text | References | PDF (1.3 MB)
  • 235 Views
  • 15 CrossRef citations
  • 0Altmetric
Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors
Elnaz Faghfuri, Shekoufeh Nikfar, Kamal Niaz, Mohammad Ali Faramarzi & Mohammad Abdollahi
Pages: 317-330
Published online: 30 Jan 2018
AbstractforMitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors | Full Text | References | PDF (1.1 MB)
  • 470 Views
  • 16 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Pharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia
Marco Falcone, Pierluigi Viale, Giusy Tiseo & Manjunath Pai
Pages: 331-340
Published online: 31 Jan 2018
AbstractforPharmacokinetic drug evaluation of avibactam + ceftazidime for the treatment of hospital-acquired pneumonia | Full Text | References | PDF (813.9 KB)
  • 788 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis
Francesco Patti, Clara G Chisari, Emanuele D’Amico & Mario Zappia
Pages: 341-352
Published online: 30 Jan 2018
AbstractforPharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis | Full Text | References | PDF (925.4 KB)
  • 230 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Pharmacokinetic drug evaluation of opicapone for the treatment of Parkinson’s disease
Marina Svetel, Aleksandra Tomić, Nikola Kresojević & Vladimir Kostić
Pages: 353-360
Published online: 24 Jan 2018
AbstractforPharmacokinetic drug evaluation of opicapone for the treatment of Parkinson’s disease | Full Text | References | PDF (728.2 KB)
  • 362 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Pharmacokinetic/pharmacodynamic drug evaluation of enzalutamide for treating prostate cancer
Jeong Hee Hong
Pages: 361-369
Published online: 13 Feb 2018
AbstractforPharmacokinetic/pharmacodynamic drug evaluation of enzalutamide for treating prostate cancer | Full Text | References | PDF (743.7 KB)
  • 471 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Sgemaglutide in type 2 diabetes – is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?
Sheila A. Doggrell
Pages: 371-377
Published online: 23 Feb 2018
AbstractforSgemaglutide in type 2 diabetes – is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)? | Full Text | References | PDF (527.4 KB)
  • 801 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications
Gianluca D’Onofrio et al.
Editorial | Published online: 31 May 2024
Free Access
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles